Abbott India

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE358A01014
  • NSEID: ABBOTINDIA
  • BSEID: 500488
INR
26,531.60
814.75 (3.17%)
BSENSE

Nov 20

BSE+NSE Vol: 11.93 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 919728,
    "name": "Abbott India",
    "stock_name": "Abbott India",
    "full_name": "Abbott India Ltd.",
    "name_url": "stocks-analysis/abbott-india",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "26,531.60",
    "chg": 814.75,
    "chgp": "3.17%",
    "dir": 1,
    "prev_price": "25,716.85",
    "mcapval": "54,831.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500488,
    "symbol": "ABBOTINDIA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE358A01014",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "11.93 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/abbott-india-919728-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Abbott India Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/abbott-india-ltd-is-rated-hold-by-marketsmojo-4260550",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AbbottIndiaLtd_mojoScore_4260550.png",
        "date": "2026-11-13 10:12:22",
        "description": "Abbott India Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 8 November 2026. While the rating was revised on that date, the analysis below reflects the stock’s current fundamentals, returns, and financial metrics as of 13 November 2026, providing investors with an up-to-date view of the company’s position in the market."
      },
      {
        "title": "Abbott India Gains 2.92%: 4 Key Factors Shaping This Week’s Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/abbott-india-gains-292-4-key-factors-shaping-this-weeks-momentum-4255394",
        "imagepath": "",
        "date": "2026-11-07 15:00:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Stock opens week at Rs.25,783.50 with 0.74% gain</p>\n                    <p><strong>4 Nov:</strong> Intraday high of Rs.26,833.75 on 5.4% surge</p>\n                    <p><strong>5 Nov:</strong> Mixed technical signals emerge amid 5.20% price rally</p>\n                    <p><strong>6 Nov:</strong> Q2 FY27 results confirm continued growth momentum</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.25,783.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.26,340.05</div..."
      },
      {
        "title": "Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/abbott-india-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4251443",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AbbottIndiaLtd_technicaldot_4251443.png",
        "date": "2026-11-05 08:05:00",
        "description": "Abbott India Ltd. has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish trend as of late September 2026. Despite a strong intraday rally pushing the stock price to ₹27,420, technical indicators present a complex picture, with bearish signals dominating monthly charts while weekly and daily measures show mixed or mildly bullish tendencies. This nuanced technical landscape warrants a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Abbott India Ltd: Valuation Shifts Signal Heightened Price Premium in Pharmaceuticals Sector",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/abbott-india-ltd-valuation-shifts-signal-heightened-price-premium-in-pharmaceuticals-sector-4251297",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AbbottIndiaLtd_valuationdot_4251297.png",
        "date": "2026-11-05 08:02:31",
        "description": "Abbott India Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating, driven by elevated price-to-earnings and price-to-book ratios. Despite robust return metrics and solid market performance over the long term, the stock’s current premium valuation raises questions about its price attractiveness relative to peers and historical averages."
      },
      {
        "title": "Abbott India Ltd. Surges 5.4% to Day's High of Rs 26,833.75 — Outperforms Sector by 3.8 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/abbott-india-ltd-hits-intraday-high-with-strong-54-surge-on-4-nov-2026-4250985",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AbbottIndiaLtd_priceRelatedfactors_4250985.png",
        "date": "2026-11-04 15:18:28",
        "description": "The Sensex rose 0.39% on 4 Nov 2026, yet Abbott India Ltd. outpaced the broader market with a 5.4% gain, outperforming its Pharmaceuticals &amp; Biotechnology sector by 3.8 percentage points. This strong single-session performance rewrites the short-term narrative for the mid-cap stock, which has been on a steady upward trajectory over the past three days."
      },
      {
        "title": "Abbott India Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/abbott-india-ltd-is-rated-sell-by-marketsmojo-4246332",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AbbottIndiaLtd_mojoScore_4246332.png",
        "date": "2026-11-01 10:10:33",
        "description": "Abbott India Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Abbott India Ltd: Valuation Shifts Signal Heightened Price Risk Amid Strong Fundamentals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/abbott-india-ltd-valuation-shifts-signal-heightened-price-risk-amid-strong-fundamentals-4242698",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AbbottIndiaLtd_valuationdot_4242698.png",
        "date": "2026-10-29 08:01:17",
        "description": "Abbott India Ltd has recently undergone a significant shift in its valuation parameters, moving from an expensive to a very expensive rating. Despite robust operational metrics and a solid return profile, the stock’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios raise questions about its price attractiveness relative to historical levels and peer benchmarks."
      },
      {
        "title": "Abbott India Ltd. is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/abbott-india-ltd-is-rated-sell-4231736",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AbbottIndiaLtd_mojoScore_4231736.png",
        "date": "2026-10-21 10:10:38",
        "description": "Abbott India Ltd. is rated Sell by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 October 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Abbott India Ltd Declines 1.18%: Bearish Momentum and Valuation Concerns Shape the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/abbott-india-ltd-declines-118-bearish-momentum-and-valuation-concerns-shape-the-week-4221210",
        "imagepath": "",
        "date": "2026-10-10 14:03:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Oct 5:</strong> Technical momentum shifts to bearish amid market volatility</p>\n                    <p><strong>Oct 6:</strong> Valuation grade downgraded from 'very expensive' to 'expensive'</p>\n                    <p><strong>Oct 9:</strong> Stock rebounds with a 1.44% gain on positive market sentiment</p>\n                    <p><strong>Week Summary:</strong> Stock closes at Rs.25,999.85, down 1.18% vs Sensex -0.57%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.26,310.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Wee..."
      }
    ],
    "total": 92,
    "sid": "919728",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/abbott-india-919728"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Nov-2026",
      "details": "Newspaper Advertisement of the Unaudited Financial Results of the Company for the quarter and half year ended on September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026.",
      "datetime": "05-Nov-2026",
      "details": "Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "05-Nov-2026",
      "details": "Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Abbott India Ltd. has declared <strong>5250%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

06-Nov-2026 | Source : BSE

Newspaper Advertisement of the Unaudited Financial Results of the Company for the quarter and half year ended on September 30 2026.

Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026.

05-Nov-2026 | Source : BSE

Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.

Board Meeting Outcome for Outcome Of Board Meeting

05-Nov-2026 | Source : BSE

Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Abbott India Ltd. has declared 5250% dividend, ex-date: 24 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available